Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.1K Sell
320
-182
-36% -$21.3K 0.03% 156
2026
Q1
$60.3K Buy
502
+152
+43% +$17.5K 0.04% 120
2025
Q4
$36.8K Buy
+350
New +$32.9K 0.03% 161

Other funds holding MRK

Entrust Financial's MRK Position: Q2 2026 in Review

Entrust Financial reduced its Merck (MRK) stake by 36% in Q2 2026, selling an estimated $21.3K and leaving 320 shares worth $41.1K. The position accounts for 0.03% of the portfolio, ranked #156.

Entrust Financial first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $60.3K in Q1 2026. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Entrust Financial held 320 shares of Merck worth $41.1K as of Q2 2026.
  • Entrust Financial sold 182 Merck shares in Q2 2026, an estimated $21.3K.
  • Merck made up 0.03% of Entrust Financial's portfolio in Q2 2026, its #156 holding.
  • Entrust Financial first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Entrust Financial's Merck position peaked at $60.3K in Q1 2026.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Entrust Financial's 13F filing for Q2 2026, filed 20 Jul 2026.